ancitabine has been researched along with Hematologic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberto, P; Brugarolas, A; Cavalli, F; Gangji, D; Hansen, HH; Rozencweig, M; Siegenthaler, P; Sylvester, R | 1 |
1 trial(s) available for ancitabine and Hematologic Diseases
| Article | Year |
|---|---|
Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial co
Topics: Ancitabine; Breast Neoplasms; Cytarabine; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Hematologic Diseases; Humans; Lung Neoplasms; Neoplasms | 1978 |